Accuracy of diagnostic mammography at facilities serving vulnerable women
- PMID: 20966780
- PMCID: PMC3689881
- DOI: 10.1097/MLR.0b013e3181f380e0
Accuracy of diagnostic mammography at facilities serving vulnerable women
Abstract
Background: Breast cancer missed on diagnostic mammography may contribute to delayed diagnoses, whereas false-positive results may lead to unnecessary invasive procedures. Whether accuracy of diagnostic mammography at facilities serving vulnerable women differs from other facilities is unknown.
Objective: To compare the interpretive performance of diagnostic mammography at facilities serving vulnerable women to those serving nonvulnerable women.
Design: We examined 168,251 diagnostic mammograms performed at Breast Cancer Surveillance Consortium facilities from 1999 to 2005. We used hierarchical logistic regression to compare sensitivity, false positive rates, and cancer detection rates.
Subjects: Women aged between 40 and 80 years underwent diagnostic mammography to evaluate an abnormal screening mammogram or breast problem.
Measures: Facilities were assigned vulnerability indices according to the populations served based on the proportion of mammograms performed on women with lower educational attainment, racial/ethnic minority status, limited household income, or rural residences.
Results: Sensitivity of diagnostic mammography did not vary significantly across vulnerability indices adjusted for patient-level characteristics, but false-positive rates for diagnostic mammography examinations to evaluate a breast problem were higher at facilities serving vulnerable women defined as those with lower educational attainment (odds ratio [OR], 1.39; 95% confidence interval [CI]: 1.08, 1.79); racial/ethnic minorities (OR, 1.32; 95% CI: 0.98, 1.76); limited income (OR, 1.34; 95% CI: 1.08, 1.66); and rural residence (OR, 1.55; 95% CI: 1.27, 1.88).
Conclusions: Diagnostic mammography to evaluate a breast problem at facilities serving vulnerable women had higher false positive rates than at facilities serving nonvulnerable women. This may reflect concerns that vulnerable populations may be less likely to follow-up after abnormal diagnostic mammography or concerns that such populations have higher cancer prevalence.
Similar articles
-
Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.J Med Screen. 2016 Mar;23(1):24-30. doi: 10.1177/0969141315591616. Epub 2015 Jun 15. J Med Screen. 2016. PMID: 26078275 Free PMC article.
-
Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women.Med Care. 2012 Mar;50(3):210-6. doi: 10.1097/MLR.0b013e3182407c8a. Med Care. 2012. PMID: 22186768 Free PMC article.
-
Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.Med Care. 2013 Apr;51(4):307-14. doi: 10.1097/MLR.0b013e318280f04c. Med Care. 2013. PMID: 23358386 Free PMC article.
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
-
Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. PMID: 26866210 Free Books & Documents. Review.
Cited by
-
Identifying key barriers to effective breast cancer control in rural settings.Prev Med. 2021 Nov;152(Pt 2):106741. doi: 10.1016/j.ypmed.2021.106741. Epub 2021 Jul 22. Prev Med. 2021. PMID: 34302837 Free PMC article.
-
The Challenges of Screening Mammography in Racial/Ethnic Minority Populations in the United States: A mini-review and observations from a predominantly Hispanic community.J Cancer Treatment Diagn. 2018;2(2):16-20. Epub 2018 Apr 5. J Cancer Treatment Diagn. 2018. PMID: 30112517 Free PMC article.
-
Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):446-453. doi: 10.1158/1055-9965.EPI-17-0009. Epub 2018 Jan 30. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29382701 Free PMC article.
-
Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST).Med Care. 2015 Aug;53(8):673-8. doi: 10.1097/MLR.0000000000000393. Med Care. 2015. PMID: 26125419 Free PMC article.
-
Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.J Med Screen. 2016 Mar;23(1):24-30. doi: 10.1177/0969141315591616. Epub 2015 Jun 15. J Med Screen. 2016. PMID: 26078275 Free PMC article.
References
-
- Sickles EA, Miglioretti DL, Ballard-Barbash R, et al. Performance benchmarks for diagnostic mammography. Radiology. 2005;235:775–790. - PubMed
-
- Jensen A, Vejborg I, Severinsen N, et al. Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer. 2006;119:183–191. - PubMed
-
- Barlow WE, Lehman CD, Zheng Y, et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst. 2002;94:1151–1159. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 CA063740/CA/NCI NIH HHS/United States
- U01CA69976/CA/NCI NIH HHS/United States
- U01CA70013/CA/NCI NIH HHS/United States
- U01 CA086082/CA/NCI NIH HHS/United States
- U01CA63736/CA/NCI NIH HHS/United States
- U01CA86082/CA/NCI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- K08 HS018090/HS/AHRQ HHS/United States
- U01 CA063740-15/CA/NCI NIH HHS/United States
- K24 CA125036/CA/NCI NIH HHS/United States
- U01CA70040/CA/NCI NIH HHS/United States
- U01CA63740/CA/NCI NIH HHS/United States
- 1 K08 HS018090-01/HS/AHRQ HHS/United States
- U01 CA070040/CA/NCI NIH HHS/United States
- U01 CA063731/CA/NCI NIH HHS/United States
- U01 CA086076/CA/NCI NIH HHS/United States
- U01 CA069976/CA/NCI NIH HHS/United States
- U01CA86076/CA/NCI NIH HHS/United States
- U01 CA063736/CA/NCI NIH HHS/United States
- U01 CA070013/CA/NCI NIH HHS/United States
- U01CA63731/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
